Literature DB >> 15259371

Quality indicators and specifications for the extra-analytical phases in clinical laboratory management.

Carmen Ricós1, Montserrat García-Victoria, Blanca de la Fuente.   

Abstract

BACKGROUND: Quality management systems should cover all the steps involved in the overall testing and non-testing processes. AIM: To identify quality indicators for extra-analytical processes in the clinical laboratory and to specify acceptability limits, in order to provide a useful tool for continuous improvement of laboratory service.
METHODS: A literature review by Medline search was performed using the keywords: Q-Tracks and Q-probes alone, and management, error, mistake, and indicator crossed with quality, laboratory and medicine. The indicators retrieved were organized according to the various laboratory processes. Their expression was standardized in relation to the total activity of each process reported in each paper reviewed. The magnitude of the errors reported was considered to be the current state of the art for the extra-analytical step and was proposed as the quality specification.
RESULTS: Examples of indicators and specifications for the pre-analytical process: Analytical request: Error in patient identification (0.08%), request unintelligible (0.1%). SAMPLING: Requested but not collected (7%), redraws (2%). Transport and reception of samples: Inadequate transportation conditions (0.005%), hemolyzed sample (0.2%). Examples of indicators and specifications for the post-analytical process: Report validation: Test not performed (1.4%), test performed but not requested (1.1%). Intra-laboratory reports: Laboratory reporting errors (0.05%), delivery outside specified time (11%). Consulting service: average time to communicate critical values for inpatients (6 min).
CONCLUSIONS: These extra-analytical indicators and their specifications, expressed in a standardized manner, constitute a preliminary basis for comparison of individual laboratory performance with the purpose of improving laboratory quality.

Entities:  

Mesh:

Year:  2004        PMID: 15259371     DOI: 10.1515/CCLM.2004.100

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  20 in total

Review 1.  Effectiveness of barcoding for reducing patient specimen and laboratory testing identification errors: a Laboratory Medicine Best Practices systematic review and meta-analysis.

Authors:  Susan R Snyder; Alessandra M Favoretto; James H Derzon; Robert H Christenson; Stephen E Kahn; Colleen S Shaw; Rich Ann Baetz; Diana Mass; Corinne R Fantz; Stephen S Raab; Milenko J Tanasijevic; Edward B Liebow
Journal:  Clin Biochem       Date:  2012-06-28       Impact factor: 3.281

Review 2.  Laboratory results that should be ignored.

Authors:  Dirk M Elston
Journal:  MedGenMed       Date:  2006-10-11

3.  The cost-benefit ratio of screening pregnant women for thrombophilia.

Authors:  Gian Luca Salvagno; Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Massimo Franchi; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

4.  Laboratory turnaround time.

Authors:  Robert C Hawkins
Journal:  Clin Biochem Rev       Date:  2007-11

5.  Role of intervention on laboratory performance: evaluation of quality indicators in a tertiary care hospital.

Authors:  Rachna Agarwal; Sujata Chaturvedi; Neelam Chhillar; Renu Goyal; Ishita Pant; Chandra B Tripathi
Journal:  Indian J Clin Biochem       Date:  2012-01-07

6.  Influence of method of specimen collection on various preanalytical sample quality indicators in EDTA blood collected for cell counting.

Authors:  Tester F Ashavaid; Sucheta P Dandekar; S Khodaiji; M H Ansari; Adarsh Pal Singh
Journal:  Indian J Clin Biochem       Date:  2009-12-30

Review 7.  Consensus Statement for the Management and Communication of High Risk Laboratory Results.

Authors:  Craig Campbell; Grahame Caldwell; Penelope Coates; Robert Flatman; Andrew Georgiou; Andrea Rita Horvath; Que Lam; Hans Schneider
Journal:  Clin Biochem Rev       Date:  2015-08

8.  Clinical laboratory as an economic model for business performance analysis.

Authors:  Vikica Buljanović; Hrvoje Patajac; Mladen Petrovecki
Journal:  Croat Med J       Date:  2011-08-15       Impact factor: 1.351

9.  Quality assessment of an interferon-gamma release assay for tuberculosis infection in a resource-limited setting.

Authors:  Nguyen T L Hang; Naoki Ishizuka; Naoto Keicho; Le T Hong; Do B Tam; Vu T X Thu; Ikumi Matsushita; Nobuyuki Harada; Kazue Higuchi; Shinsaku Sakurada; Luu T Lien
Journal:  BMC Infect Dis       Date:  2009-05-18       Impact factor: 3.090

10.  Analysis of factors influencing the generation of unqualified clinical samples and measures to prevent this generation.

Authors:  Xiaofei Lai; Ping Yang; Yuhong Zhang; Ju Cao; Liping Zhang
Journal:  Ann Lab Med       Date:  2012-04-18       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.